Clinical trial

2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab

NCT00600340

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention Bevacizumab and Paclitaxel Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Bevacizumab and Capecitabine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE3

Conditions

Metastatic Breast Cancerunresolved

Interventions

Bevacizumab and PaclitaxelBIOLOGICAL

Bevacizumab and CapecitabineBIOLOGICAL

Sponsors & collaborators

Central European Cooperative Oncology Grouplead sponsor

Mapped research locations

LinzAustria3 BudapestHungary2 ViennaAustria2 BucharestRomania2 GdanskPoland2 Tel AvivIsrael2 BratislavaSlovakia2 BelgradeSerbia2 ZagrebCroatia2 RigaLatvia2 WarsawPoland1 PragueCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00600340 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.